A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety profiles of Fluticasone Propionate 100 mcg and Salmeterol
50 mcg Inhalation Powder (test product) and ADVAIR DISKUS (fluticasone propionate 100 mcg and
salmeterol 50 mcg inhalation powder) (reference product) and to show that the efficacy of the
2 active products is superior to that of placebo in the treatment of subjects with asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Amneal Ireland Limited
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate